29.02.2024

GMP Compliance Adviser Update No 1/2024

Focuses of this update are: Barrier systems (RABS and isolators) for sterile manufacturing and manufacture of terminally sterilised products


The following overview lists the topics covered with this Update:

GMP in Practice

Chapter 3 Premises

  • 3.F Barrier systems (RABS and isolators) for sterile manufacturing

Chapter 12 Sterile Production

  • 12.C Manufacture of terminally sterilised products

GMP Regulations

Chapter C EU Directives and Guidelines

  • C.7 Compilation of Union Procedures on Inspections and Exchange of Information
  • C.19 Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Chapter E ICH Guidelines

  • E.2 ICH Q2(R2) Validation of Analytical Procedures
  • E.5.A ICH Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin
  • E.14 ICH Q14 Analytical Procedure Development

 

To the knowledge portal

More info on the GMP Compliance Adviser